ID
16022
Description
Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00201682
Link
https://clinicaltrials.gov/show/NCT00201682
Keywords
Versions (1)
- 6/26/16 6/26/16 -
Uploaded on
June 26, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Chronic Lymphocytic Leukemia NCT00201682
Eligibility Chronic Lymphocytic Leukemia NCT00201682
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
pregnant or lactating
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0032961
- UMLS CUI [1,2]
- C0006147
Description
ECOG performance status
Data type
boolean
Alias
- UMLS CUI [1]
- C1520224
Description
life expectancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0023671
Description
high bilirubin or creatinine
Data type
boolean
Alias
- UMLS CUI [1]
- C0005437
- UMLS CUI [2]
- C0201976
Similar models
Eligibility Chronic Lymphocytic Leukemia NCT00201682
- StudyEvent: Eligibility
C0023449 (UMLS CUI [1,2])
C1178562 (UMLS CUI [1,2])
C0021079 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
C0201976 (UMLS CUI [2])